Ra Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Ra Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ra Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ra Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ra Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11814445B2 | Grant | Cyclic polypeptides for pcsk9 inhibition | A61K38/00; C07K7/02 | November 14, 2023 |
| US11814444B2 | Grant | Cyclic polypeptides for pcsk9 inhibition | A61K38/00; C07K7/02 | November 14, 2023 |
| WO2023215586A1 | Application | Treatment of myasthenia gravis with zilucoplan | G01N33/563 | November 09, 2023 |
| WO2023215587A1 | Application | Treatment of myasthenia gravis with zilucoplan | A61K38/12; A61K38/13; A61K45/06; A61P21/04; G01N2800/28; G01N33/564; G01N33/944 | November 09, 2023 |
| CA2949985C | Grant | Modulation of complement activity | A61P13/00; A61P25/00; A61P17/02; A61K38/00; A61P27/02; A61P29/00; Y02A50/30; A61P7/00; A61P9/00; C07K16/00; A61K47/645; C07K14/472; C07K7/06; A61K38/08; C07K7/64; A61K47/64; A61K38/10; C07K7/08; A61P13/02; A61P13/12; A61P37/06 | October 17, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer